(MENAFN- GlobeNewsWire - Nasdaq) Dublin, Oct. 28, 2026 (GLOBE NEWSWIRE) -- "Microarray Scanners - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global microarray scanners market was valued at US$986.1 million in 2025 and is projected to reach US$1.6 billion by 2032, advancing at a compound annual growth rate (CAGR) of 7.2%. Market expansion is being supported by growing investment in genomics, precision medicine, molecular diagnostics, pharmaceutical research and high-throughput biological analysis.
Technology Innovation Strengthens Microarray Scanner Performance
Microarray scanner technology continues to evolve through improvements in imaging resolution, scanning speed, signal-to-noise performance and multiplexing. Pharmaceutical companies, diagnostic laboratories and research institutions are deploying advanced systems for gene expression profiling, genotyping, biomarker discovery, protein analysis and drug development.
Artificial intelligence and machine learning are increasingly being integrated into scanner software to support real-time analytics, pattern recognition and interpretation of complex biological data. These capabilities are especially relevant in oncology research, where microarray platforms support mutation analysis, patient stratification and treatment-response monitoring. Laser-based fluorescence systems and confocal scanning technologies are also improving sensitivity, reproducibility and the detection of low-abundance biological material.
Applications Expand Beyond Traditional Genomics Research
Demand for versatile microarray scanning platforms is rising as life sciences research expands across transcriptomics, proteomics and epigenetics. Additional applications in agricultural genomics, environmental monitoring, infectious disease surveillance, neurogenetics and stem cell research are broadening the global addressable market.
The growth of multiplex assays is encouraging manufacturers to develop systems that accommodate diverse array configurations while maintaining consistent calibration and imaging performance. Interoperability has also become an important purchasing consideration as laboratories adopt cloud-based platforms, open data-processing tools and collaborative analytical environments.
End-Use Demand Shapes Product Development
Diagnostic laboratories represent a key end-use market as personalized medicine and early disease detection increase demand for rapid molecular profiling. Buyers are prioritizing automation, reliability, streamlined workflows and minimal maintenance. Pharmaceutical and biotechnology companies are incorporating microarray scanners into drug discovery, lead identification, validation and diagnostic assay development.
Hospitals and clinical research organizations are also increasing their use of genomic assays to support therapy selection and patient classification. Rising rates of cancer, cardiovascular disease and neurological disorders are reinforcing demand for advanced molecular diagnostic workflows. Government and institutional funding for life sciences research is further supporting scanner adoption, particularly in emerging markets developing genomic research infrastructure.
Microarray Scanners Market Segmentation
Product type: Fluorescence microarray scanners, charge-coupled device microarray scanners, colorimetric microarray scanners and other product types. Application: Gene expression analysis, protein microarrays, drug discovery, genotyping and SNP analysis, and other applications. End use: Hospitals and clinics, pharmaceutical and biotechnology companies, diagnostic laboratories, academic and research institutes, and other end users. Geographic coverage: United States, Canada, Japan, China, Europe, Asia-Pacific, Latin America, the Middle East and Africa.
Key Market Insights
The fluorescence microarray scanners segment is projected to reach US$709.4 million by 2032, expanding at a CAGR of 5.8%. The charge-coupled device microarray scanners segment is forecast to grow at a CAGR of 8.8% during the analysis period. The United States microarray scanners market was valued at US$268.7 million in 2025. China is forecast to reach US$339.7 million by 2032, growing at a CAGR of 10.8%. Japan, Canada, Germany and the broader Asia-Pacific market are expected to provide additional growth opportunities.
Principal Microarray Scanners Market Growth Drivers
Market growth is being propelled by automated high-resolution systems, integration with advanced data-analysis platforms and increasing demand for scalable research workflows. Expanding direct-to-consumer genetic testing and personalized healthcare services are creating further commercial opportunities. Microarray analysis is also gaining importance in agriculture, environmental science and biosecurity, extending adoption across new industries and geographic markets.
Report Scope and Strategic Value
The report provides independent annual sales analysis and market forecasts from 2025 through 2032. It examines market trends, growth drivers, restraints, segment performance, regional developments and the competitive landscape. The analysis is designed to help organizations identify revenue opportunities, evaluate investment priorities and support strategic business decisions.
Company coverage includes Agilent Technologies, Arrayit Corporation, Ayoxxa Biosystems, BioMicro Systems, Bio-Rad Laboratories, CapitalBio Technology, Ditabis, Eppendorf, GE Healthcare, Illumina, Innopsys, Molecular Devices, PerkinElmer, Phalanx Biotech Group, Roche Diagnostics, STMicroelectronics and Thermo Fisher Scientific, including Affymetrix and Applied Biosystems.
Domain Expert Insights
The report tracks early market signals emerging from expert discussions, company activity, scientific conferences and market-relevant developments. Insights draw on domain expertise spanning industry, enterprise and academia, providing context beyond conventional secondary research. Validated intelligence incorporates corporate disclosures, annual reports, institutional publications, conference sessions, keynotes, panel discussions and other credible sources. The analysis connects emerging signals with strategic market direction, identifying the technologies, applications and competitive developments most likely to influence future growth. Market share is assessed where analytically relevant, including regional evaluations that reflect differences in competitive structure and market maturity. In-depth company intelligence examines organizations participating in and shaping the global microarray scanners market.
Key Attributes
CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood,Senior Press Manager...
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Comments
No comment